DESMOPLASTIC SMALL ROUND CELL TUMOR
Clinical trials for DESMOPLASTIC SMALL ROUND CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new DESMOPLASTIC SMALL ROUND CELL TUMOR trials appear
Sign up with your email to follow new studies for DESMOPLASTIC SMALL ROUND CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for young patients battling aggressive cancers
Disease control Recruiting nowThis study is testing a new drug called PEEL-224, given alongside two existing cancer drugs, in adolescents and young adults whose sarcomas have returned or not responded to standard treatments. The goal is to find a safe dose and see if this three-drug combination can shrink tum…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: David S Shulman, MD • Aim: Disease control
Last updated Apr 04, 2026 00:05 UTC
-
New hope for kids with tough cancers: scientists test re-engineered immune cells
Disease control Recruiting nowThis study is testing a new type of immunotherapy for children and young adults (up to age 21) whose solid tumors have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells (T cells), modify them in a lab to better target a protein calle…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo tested for rare, aggressive cancer
Disease control Recruiting nowThis study is testing whether a combination of two chemotherapy drugs, lurbinectedin and irinotecan, can help control advanced desmoplastic small round cell tumor (DSRCT), a rare and aggressive cancer. It is for patients aged 15 and older whose cancer has spread and worsened afte…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New hope for tough cancers: trial tests Immune-Boosting drug with chemo
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called tislelizumab to standard chemotherapy works better for people with advanced soft tissue sarcoma. It will enroll 45 adults with specific types of sarcoma that cannot be removed by surgery or have spread. The main…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
New hope for kids with aggressive cancers: trial tests supercharged immune transplant
Disease control Recruiting nowThis study is testing a new type of stem cell transplant for children and young adults whose solid tumors have returned or not responded to standard treatments. Doctors are using a donor's stem cells that have been specially processed to remove certain immune cells, then combinin…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New drug trial targets tough childhood cancers that have returned
Disease control Recruiting nowThis study is testing a drug called lurbinectedin to see if it is safe and can control tumors in children and adults (age 10+) whose Ewing sarcoma or related cancers have come back after initial treatment. The drug is designed to target specific genetic changes that drive these t…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
Scientists map immune landscape of rare cancers
Knowledge-focused Recruiting nowThis study aims to learn more about how the immune system interacts with rare types of soft tissue sarcoma. Researchers will observe 400 adult patients in France who have one of nine specific rare sarcoma subtypes. The goal is to collect detailed biological and clinical informati…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Rare cancer registry seeks patients to unlock disease mysteries
Knowledge-focused Recruiting nowThis study is creating a database of health information from people diagnosed with desmoplastic small round cell tumor (DSRCT), a rare and aggressive cancer. Researchers will collect medical history and ongoing health data from up to 250 participants of any age. The goal is to ga…
Matched conditions: DESMOPLASTIC SMALL ROUND CELL TUMOR
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC